Pyxis Oncology (PYXS) Current Leases (2020 - 2026)
Pyxis Oncology (PYXS) posted quarterly Current Leases of $1.7 million for Q4 2025, up 16.69% year-over-year from $1.4 million in Q4 2024, and up 3.8% quarter-over-quarter from $1.6 million in Q3 2025.
Pyxis Oncology (PYXS) Current Leases (2020 - 2026) Analysis & Trends
Pyxis Oncology (PYXS) has reported Current Leases for 5 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases rose 16.69% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 16.69% YoY), while the FY2025 annual figure was $1.7 million, up 16.69% from the prior year.
- Current Leases climbed to $1.7 million in Q4 2025 per PYXS's latest filing, from $1.6 million in the prior quarter.
- Across five years, Current Leases topped out at $1.7 million in Q4 2025 and bottomed at $165000.0 in Q4 2021.
- Historically, Current Leases has averaged $1.1 million across 4 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2021 — Current Leases tumbled 73.17% — and 2025, when it jumped 47.84%.
- Pyxis Oncology's Current Leases stood at $165000.0 in 2021, then surged by 646.67% to $1.2 million in 2023, then increased by 17.69% to $1.4 million in 2024, then rose by 16.69% to $1.7 million in 2025.
- Business Quant data shows PYXS's Current Leases at $1.7 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Pyxis Oncology | 196.77 Mn | 163.78 Mn | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 527,000.00 |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2021 | 165,000.00 |
| Sep 30, 2021 | 325,000.00 |
| Dec 31, 2020 | 615,000.00 |